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The aim of this study was to investigate the relative burden of rhinitis and asthma on
health-related quality of life (HRQL) as a function of gender and age in the general
population. A cross-sectional, general population survey was conducted, comprising 5918
men and women aged 16–64 years. The SF-36 Health Survey was administered by mail,
along with questions regarding nasal complaints after 15 years of age and physician-
diagnosed asthma. Overall, rhinitis and asthma were each associated with impaired HRQL
compared with non-cases and the burden of these illnesses in combination was
incremental. In the age group 16–49 years, men and women with rhinitis alone had
significantly worse health profiles on most scales than non-cases, while asthmatics, with or
without rhinitis, showed further decrements on only a few scales. In the age group 50–64
years, men with rhinitis did not differ from non-cases and no differences were found
between asthmatics and rhinitis victims on any scale. In contrast, women aged 50–64 years
with rhinitis had significantly worse scores than non-cases on bodily pain and general well-
being scales (GH, VT), and asthmatics scored much lower on all scales than those with
rhinitis alone. The negative association of rhinitis and asthma with HRQL differs by age and
sex in the general population. Women aged 50–64 years with one or both ailments are
particularly affected. Such gender and age differences should be taken into consideration
in the care and treatment of patients with rhinitis and asthma.
& 2006 Published by Elsevier Ltd.Published by Elsevier Ltd.
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U. Larsson).Introduction
In Europe, the prevalence of nasal allergies, asthma and
asthmatic symptoms in adults varies greatly between and
within countries and language areas.1 Estimates of nasal
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U. Larsson et al.1292allergies and hay fever range from 10% to 41%, while the
corresponding range for asthma is between 2% and 12%.1
Each of these ailments thus constitutes a threat to public
health. Further, rhinitis and asthma are closely linked and
20–50% of patients suffering from rhinitis are also bothered
with asthma. Correspondingly, rhinitis has been shown to be
present among up to 80% of asthmatics.2
One reason for evaluating rhinitis and asthma in terms of
health-related quality of life (HRQL) in clinical trials and in
epidemiological studies is their lack of association with
traditional outcome measures such as lung function, nasal
tests and symptom scores.3 Additionally, recent research
into the properties of existing HRQL instruments has made it
possible to interpret the results in a clinically significant way
for the patient.3,4
The burden of rhinitis and asthma on HRQL has been
assessed primarily in studies of patients seeking treatment.
Rhinitis victims have been shown to report poorer physical
and mental HRQL compared with healthy persons.5,6
Impaired aspects of health include sleep, fatigue, concen-
tration, limitations in daily activities and emotional pro-
blems.5 Asthmatic patients report adverse effects on
emotions, physical activities and activities of daily life.7
Further, the severity of asthma has been shown to correlate
with the scale scores of the SF-36, in particular, physical
functioning and general health perceptions.8 Also, female
asthmatic patients report more symptoms and poorer HRQL
than male patients, but these differences are not accounted
for by disease severity.9 Strong relationships have also been
found between socioeconomic and demographic factors and
HRQL in asthmatics.10
Studies involving samples from the general population are
relatively scarce. In a comprehensive study of young adults,
rhinitis alone was found to adversely affect mental health
and well-being, more so in women than men, while the
added effect of asthma was on physical functioning alone.11
Conversely, other studies have found both rhinitis12,13 and
asthma14 to affect both mental and physical health.
The study by Leynaert et al.11 is the only population-
based study to date that has assessed the relative burden of
rhinitis and asthma in the same study. However, as noted by
the authors, their sample size prohibited them from
isolating asthma from rhinitis in their analyses. Further-
more, since their study focused on young adults (20–44
years), we know little about the relative impacts of these
illnesses on older persons. Using a large population sample
(n ¼ 5918) including adults up to the age of 64 years, the
present study sought to test the following hypotheses: Rhinitis and asthma are negatively associated with both
well-being and functioning and the burden of these
illnesses is incremental. The relationship between rhinitis and HRQL and asthma
and HRQL is dependent on gender and age.
Materials and methods
Design
A cross-sectional survey was conducted in western Sweden
by the county council of A¨lvsborg in 1997. A random sampleof 12,295 persons aged 16 years or older was mailed a
questionnaire including the SF-36 and questions on allergy,
demography and lifestyle. Rhinitis and asthma were identi-
fied using previously validated techniques.15,16 Questions
were: ‘‘Since the age of 15, have you ever had nasal
problems, such as a blocked nose, a runny nose and/or
attacks of sneezing without having a cold?’’ and ‘‘Have you
been diagnosed by a physician as having asthma?’’. An
affirmative answer to any of the questions defined the
subject as rhinitic or asthmatic, respectively. The fieldwork
was conducted between mid-February and early May and
thus not during the pollen season. A stratified, random
sample was drawn from the national civil registries by the
government agency Statistics Sweden, which also performed
the fieldwork. The sample was stratified only by munici-
pality in order to secure a large enough sample from each of
the 25 municipalities in the area. A total of 204 subjects
were excluded from the target sample due to mental and/or
physical illness or due to residing abroad. Of the remaining
12,091 persons, 8751 (72%) returned completed question-
naires. Further details of the population sample are
presented elsewhere.17
Subjects
The present analysis was restricted to the age group 16–64
years since rapid declines in physical health status, in
particular physical function (PF) and role-physical (RP),20 in
subjects above 64 was considered to confound the effect of
rhinitis and asthma on HRQL. The target sample aged 16–64
years comprised 9410 subjects and 6623 (70%) returned
completed questionnaires. The cumulative prevalence of
rhinitis and asthma in men and women divided into age
groups 16–49 and 50–64 years is given in Table 1. First-
generation immigrants (n ¼ 705) were excluded since
persons born abroad reported lower HRQL and the pre-
valence of asthma and rhinitis differs between people born
outside of Sweden and in Sweden (data not shown). The final
sample thus consisted of 5918 subjects.
Health-related quality of life (HRQL)
HRQL was assessed with the generic SF-36 Health Survey
measuring 8 domains of health: physical function (PF), role-
physical (RP), bodily pain (BP), general health (GH), vitality
(VT), social function (SF), role-emotional (RE) and mental
health (MH). The Swedish version of the SF-36 is well
documented and has shown good psychometric qualities
in different groups.18–20 All eight scale scores range from
0 to 100, with 100 representing optimal functioning and
well-being.
Statistical methods
Subjects were divided into two age groups, 16–49 and 50–64
years, since chronic obstructive pulmonary disease (COPD)
may be misdiagnosed as asthma in the age group 50 years
and above, where it is especially prevalent.21 The younger
group comprised 2038 men (mean ¼ 33 years, SD ¼ 9.8) and
2158 women (mean ¼ 33 years, SD ¼ 9.8) and the older group
consisted of 858 men (mean ¼ 56, SD ¼ 4.4) and 864 women
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Table 1 Cumulative prevalence of asthma and rhinitis in a random sample from western Sweden, by sex and age.
Allergy category Men (%) Women (%)
16–49 years 50–64 years 16–49 years 50–64 years
(n ¼ 2252) (n ¼ 959) (n ¼ 2428) (n ¼ 984)
Non-cases 58.8 63.4 57.8 58.7
Rhinitis 39.6 34.1 40.6 39.0
Asthma 7.4 7.0 6.9 8.0
Rhinitis and asthma 5.8 4.4 5.3 5.7
16-64 yrs
50
55
60
65
70
75
80
85
90
95
100
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Figure 1 SF-36 health profiles for the total group. Abbreviations: PF—physical functioning; RP—role physical; BP—bodily pain;
GH—general health; VT—vitality; SF—social functioning; RE—role emotional; MH—mental health. n for: non-cases ¼ 3477; rhinitis,
not asthma ¼ 2008; asthma, not rhinitis ¼ 101; rhinitis and asthma ¼ 308.
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Figure 2 SF-36 health profiles for the age stratum 16–49 years. Abbreviations: PF—physical functioning; RP—role physical;
BP–bodily pain; GH–general health; VT—vitality; SF—social functioning; RE—role emotional; MH—mental health. n for: non-
cases ¼ 2473; rhinitis, not asthma ¼ 1493; asthma, not rhinitis ¼ 64; rhinitis and asthma ¼ 232.
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Figure 3 SF-36 health profiles for the age stratum 50–64 years. Abbreviations: PF—physical functioning; RP—role physical;
BP—bodily pain; GH—general health; VT—vitality; SF—social functioning; RE—role emotional; MH—mental health. n for: non-
cases ¼ 1003; rhinitis, not asthma ¼ 515; asthma, not rhinitis ¼ 37; rhinitis and asthma ¼ 76.
U. Larsson et al.1294(mean ¼ 56 years, SD ¼ 4.3). In Figs. 1–3, descriptive health
profiles were given for the total group and the two age
strata, respectively. Illness was categorized into four
groups: non-cases (subjects with neither asthma nor
rhinitis), rhinitis (subjects with rhinitis but not asthma),
asthma (subjects with asthma but not rhinitis) and rhiniti-
s+asthma (subjects with both illnesses). Due to the small
sample size of the asthma group, asthmatics could not be
further divided into separate groups for younger and older
men and women, respectively. In Tables 2 and 3, illness was
thus categorized into three groups: non-cases, rhinitis and
asthma (with or without rhinitis). To test for differences in
mean value on the eight SF-36 scales between illness groups
(non-cases, rhinitis and asthma), the non-parametric Krus-
kal–Wallis’ ANOVA was used. To further assess the magnitude
of differences between the groups, a post-hoc analysis was
performed by Scheffe´’s test. Gender differences were
tested using the z-test. A 5% significance level was applied
throughout.Results
Overall, well-being and functioning according to the SF-36
were negatively associated with the presence of rhinitis
and/or asthma. The magnitude of differences, however,
varied across the SF-36 profile, as well as by age group (Figs.
1–3). In the total group (Fig. 1), rhinitis or asthma per se was
associated with impaired HRQL compared with non-cases,
and, what is more, the burden of these illnesses in
combination was incremental. This pattern of differing
profiles was valid also for the two age strata (Figs. 2 and 3),
although the magnitude of differences appeared clearer in
the older age group (Fig. 3).
Gender and age differences in SF-36 scale scores were
tested across the three groups non-cases, rhinitis and
asthma (with or without rhinitis) as shown in Tables 2 and 3.Age group 16–49 years (Table 2)
Men: The Kruskal–Wallis ANOVA yielded significant differ-
ences between at least two of the three groups on all eight
scales. Post-hoc analyses (Scheffe´ test) showed that men
with rhinitis scored significantly lower than non-cases on all
SF-36 scales, except PF, RP and RE. Although, asthmatic
males scored lower on all scales than those with rhinitis,
only the differences on PF and MH were significant. The MH
scale showed significant decrements across the three
groups.
Women: As was the case for men, the ANOVA indicated
significant differences across all scales. Post-hoc analyses
showed that women with rhinitis also scored significantly
lower than non-cases on all SF-36 scales except SF and RE.
Further, significant linear decrements across all three groups
were noted for RP and GH.
Men versus women: Women had significantly worse scores
than men on all scales in all groups, except among
asthmatics where SF, RE and MH were not significant and
among non-cases where GH was not significant.Age group 50–64 years (Table 3)
Men: As was the case for men and women aged 16–49 years,
the ANOVA indicated significant differences across all scales.
Post-hoc analyses showed, however, no significant differ-
ences between men with rhinitis and non-cases. Asthmatics
scored significantly worse than non-cases on general well-
being and mental health domains (GH, VT, MH), but did not
score significantly lower than rhinitis victims on any scale.
Women: As was the case for men and for women aged
16–49 years, the ANOVA indicated significant differences
across all scales. Post-hoc analyses showed that women with
rhinitis scored significantly worse than non-cases on bodily
pain (BP) and general well-being scales (GH, VT). Asthmatic
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Table 2 Mean SF-36 scale scores (standard error) by sex and illness group (16–49 years).
PFa RPa BPa GHa VTa SFa REa MHa
Men
Non-cases 95.8 (0.3) 90.7 (0.7) 83.5 (0.6) 82.5 (0.5) 72.0 (0.5) 91.9 (0.5) 91.0 (0.7) 83.0 (0.5)
(n ¼ 1159–1186)b
Rhinitis, not asthma 95.4 (0.4) 86.9 (1.0) 78.9 (0.9) 77.0 (0.7) 64.4 (0.8) 87.9 (0.7) 86.7 (1.1) 78.9 (0.6)
(n ¼ 674–686)b
Asthma with or without rhinitis 93.3 (1.1) 82.3 (2.5) 77.0 (2.1) 74.4 (1.7) 63.2 (1.8) 85.1 (1.9) 82.3 (2.6) 75.5 (1.7)
(n ¼ 145–150)b
Kruskal–Wallis, P-valuec 0.002 0.002 0.000 0.000 0.000 0.000 0.000 0.000
Post-hoc Scheffe´d [N R] [A] [N R] [R A] [N] [R A] [N] [R A] [N] [R A] [N] [R A] [N R] [R A] [N] [R] [A]
Women
Non-cases 94.3* (0.4) 87.0* (0.8) 80.3* (0.7) 81.4 (0.5) 66.1* (0.6) 87.7* (0.6) 87.1* (0.8) 79.8* (0.5)
(n ¼ 1217–1252)b
Rhinitis, not asthma 90.9* (0.6) 79.7* (1.3) 72.7* (0.9) 73.9* (0.8) 59.1* (0.8) 83.9* (0.8) 82.0* (1.2) 76.1* (0.7)
(n ¼ 729–744)b
Asthma with or without rhinitis 88.9* (1.2) 73.4* (3.1) 72.6* (2.2) 67.6* (2.1) 58.1* (1.9) 81.7 (1.8) 79.6 (2.9) 74.3 (1.6)
(n ¼ 146–151)b
Kruskal–Wallis, P-valuec 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Post-hoc Scheffe´d [N] [R A] [N] [R] [A] [N] [R A] [N] [R] [A] [N] [R A] [N R] [R A] [N R] [R A] [N] [R A]
*Significantly (z-test, Po0.05) different from men of the same age, illness grouping and SF-36 scale.
aPF ¼ physical functioning, RP ¼ role physical, BP ¼ bodily pain, GH ¼ general health, VT ¼ vitality, SF ¼ social functioning,
RE ¼ role emotional, MH ¼ mental health.
bThe number of individuals for different scales differs due to item non-response.
cKruskal–Wallis non-parametric ANOVA: P-valueo0.05 indicates that two or more illness groups are different from one another.
dScheffe´’s test: N ¼ Non-cases, R ¼ Rhinitis, A ¼ Asthma with or without rhinitis; groups in different sets of brackets are
significantly different (Po 0.05).
Quality of life in the allergic population 1295women scored significantly worse than both non-cases and
the rhinitis group on all health domains.
Men versus women: Among non-cases, women scored
significantly worse than men on only two scales (PF, BP).
Women with rhinitis scored significantly lower than their
male counterparts on PF, VT and SF, whereas women
asthmatics rated their health significantly worse on PF, RP,
BP, VT, RE and MH.Discussion
Our results generally supported our hypothesis that rhinitis
and asthma are associated with impaired well-being and
functioning as measured by the SF-36; however, we found
only limited evidence suggesting that the burden of these
illnesses is incremental. Our respondents aged 16–64 years
with rhinitis and asthma each differed from non-cases,
but victims of these two illnesses did not differ from one
another on any HRQL domain. However, the burden of these
illnesses in combination was associated with the worst
health profile (Fig. 1).
In dividing our sample into younger (16–49 years) versus
older (50–64 years) respondents, we found essentially the
same pattern of results in the younger group as we had
found for the total group. Our results for rhinitis sufferers
are consistent with those of Meltzer et al.,12 but contrast
with those of Leynaert et al.11 who in a population study of
young adults (20–44 years) found that HRQL impairmentswere primarily on mental health dimensions in patients with
rhinitis and primarily on physical health dimensions in those
with asthma with or without rhinitis. There are several
possible reasons for these discrepancies. Since we asked
about lifetime rhinitis after the age of 15 years, our sample
probably consisted of rhinitis sufferers with problems
ranging from none or negligible to severe. Leynaert et al.,
on the other hand, asked for present symptoms of both
seasonal and perennial rhinitis. Our rhinitics would probably
have scored lower on the SF-36 if our study had been
conducted during pollen season, and thus differences
between this group (and the group of asthmatics plus
rhinitis victims) and non-cases would have been clearer, as
has been shown by Laforest et al.22
Discrepancies between the young adults of Leynaert
et al.11 and those of our study may possibly also be
accounted for by differences in study populations.
In the older group (50–64 years), however, a distinct
pattern was found suggesting an incremental burden of
these illnesses: rhinitis victims rated their physical and
mental health worse than non-cases, asthmatics worse than
those with rhinitis, and those with asthma and rhinitis worse
than those with asthma alone. This finding, that the degree
differences in the HRQL impairments associated with asthma
and rhinitis vary in relation to age, should be taken into
consideration in treatment programs for these illnesses.
Support was found for our second hypothesis that the
relationship between rhinitis/asthma and HRQL is both age
and gender-dependent. Our results generally confirmed
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Table 3 Mean SF-36 scale scores (standard error) by sex and illness group (50–64 years).
PFa RPa BPa GHa VTa SFa REa MHa
Men
Non-cases 87.1 (0.8) 82.0 (1.5) 75.4 (1.1) 74.7 (0.9) 71.0 (0.9) 89.3 (0.9) 90.3 (1.1) 83.8 (0.7)
(n ¼ 502–526)b
Rhinitis, not asthma 83.5 (1.4) 74.4 (2.5) 68.8 (1.7) 68.2 (1.5) 63.8 (1.6) 85.5 (1.5) 83.6 (2.1) 78.0 (1.3)
(n ¼ 258–268)b
Asthma with or without rhinitis 83.5 (2.6) 78.2 (5.2) 72.1 (4.1) 61.1 (3.5) 60.3 (3.2) 83.9 (3.0) 84.8 (4.4) 76.7 (3.2)
(n ¼ 56–60)b
Kruskal–Wallis, P-valuec 0.000 0.003 0.000 0.000 0.000 0.000 0.008 0.001
Post-hoc Scheffe´d [N R A] [N R A] [N R A] [N R] [R A] [N R] [R A] [N R A] [N R A] [N R] [R A]
Women
Non-cases 84.7* (0.9) 82.0 (1.6) 72.4* (1.3) 74.6 (1.0) 70.2 (1.0) 88.1 (0.9) 89.7 (1.3) 81.7 (0.9)
(n ¼ 476–499)b
Rhinitis, not asthma 80.2* (1.4) 73.8 (2.4) 63.9 (1.7) 65.0 (1.5) 60.2* (1.5) 83.1* (1.5) 84.5 (1.9) 78.0 (1.2)
(n ¼ 269–282)b
Asthma with or without rhinitis 68.3* (3.1) 52.9* (5.9) 47.0* (3.4) 50.3 (3.4) 47.1* (3.1) 70.4 (3.5) 66.1* (5.6) 64.9* (2.7)
(n ¼ 68–75)b
Kruskal–Wallis, P-valuec 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Post-hoc Scheffe´d [N R] [A] [N R] [A] [N] [R] [A] [N] [R] [A] [N] [R] [A] [N R] [A] [N R] [A] [N R] [A]
*Significantly (z-test, Po0.05) different from men of the same age, illness grouping and SF-36 scale.
aPF ¼ physical functioning, RP ¼ role physical, BP ¼ bodily pain, GH ¼ general health, VT ¼ vitality, SF ¼ social functioning,
RE ¼ role emotional, MH ¼ mental health.
bThe number of individuals for different scales differs due to item non-response.
cKruskal–Wallis non-parametric ANOVA: P-valueo0.05 indicates that two or more illness groups are different from one another.
dScheffe´’s test: N ¼ Non-cases, R ¼ Rhinitis, A ¼ Asthma with or without rhinitis; groups in different sets of brackets are
significantly different (Po 0.05).
U. Larsson et al.1296previously reported findings of age differences in the
associations of rhinitis and asthma with HRQL; however,
we found that such differences were modulated by gender.
In the younger age group, women reported significantly
worse HRQL on most or all SF-36 scales than men among non-
cases and both illness groups, whereas few gender differ-
ences were apparent in the older group among non-cases
and rhinitis victims. Furthermore, younger male and female
rhinitis and asthma victims were distinguished from non-
cases on most SF-36 domains, whereas older men with
rhinitis did not differ from non-cases on any scale and the
burden of asthma affected only three scales. On the other
hand, older women with rhinitis differed significantly from
non-cases on three scales and on all health domains from
those with asthma with or without rhinitis. Thus, although it
is a common finding that women in general rate their HRQL
poorer than men,17,20 our results suggested that the degree
and breadth of this relationship may be moderated by both
age and illness.
Several explanations for gender differences in the
association between rhinitis/asthma and HRQL are possible.
One that has been mentioned is that women suffer from
more severe rhinitis or asthma than men do. However, two
studies on asthma found female patients to report worse
HRQL in response to the same severity level of asthma as
their male counterparts experienced.9,23 Additionally, gen-
der differences may be due to differences in response to the
same disease and severity level. It has been suggested that
women are more emotionally distressed by the sheerpresence of asthma symptoms, while men do not react until
their symptoms become severe and long-standing.24
The prevalence of rhinitis and asthma in our study
(Table 1) differs only slightly from prevalence rates reported
in other Swedish population studies. Supporting the validity
of our self-report technique,15,16 two recent studies using
the same technique reported similar prevalence estimates
of rhinitis.15,25 Montne´mery et al.25 found that 33% of adults
20–59 years in southern Sweden reported significant nasal
symptoms: a combination of blocked nose, sneezing, nasal
discharge and thick yellow nasal discharge. Hellgren et al.15
documented rhinitis in the same Swedish county using the
same self-report technique and reported a prevalence
among women and men aged 21–51 years of 42% and 36%,
respectively (cf. 41% and 40% in our study).
Asthma prevalence estimated by self-report varied
between 5.8% and 6.8% in Swedish studies within ECRHS26
(cf. 6.9% and 7.4% for women and men, respectively, in our
study). Our higher prevalence rates possibly owe to the fact
that we asked about lifetime rhinitis and asthma rather than
current symptoms, as suggested by Ja¨rvholm et al.21
Montne´mery et al.25 found an asthma prevalence of 5.5%
in their study.
Evaluating the accuracy of self-report for identifying
asthma is complicated by the fact that there exist no
universally accepted diagnostic criteria for asthma. Hence,
epidemiological methods, i.e., self-reported asthma, have
shown high specificity and somewhat lower sensitivity in
predicting clinically assessed asthma.16,27 A recent Swedish
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Quality of life in the allergic population 1297population-based case-control study reported a specificity
of 99% and a sensitivity of 36%.28 The lower sensitivity
estimates may in part be explained by the fact that as many
as one-third of asthmatics have been shown to be unaware
that they have this illness.27 Further, asthma is commonly
misdiagnosed as COPD with age. However, higher sensitivity
(90% and 95%) and specificity (67% and 97%) estimates have
been obtained in predicting clinically assessed rhinitis.29,30
These discrepancies in sensitivity should be considered when
prevalence figures for rhinitis and asthma are discussed.
Certain confounders may have influenced our results. For
example, allergic and non-allergic rhinitis could not be
distinguished in the questionnaire data and could therefore
not be analysed separately. Moreover, although we con-
trolled for other potential confounders (e.g. immigrant
status), we did not control for co-morbidity. It is possible
that our results, in particular regarding women 50–64 years,
are in part due to concomitant ailments. However, no
gender differences were found regarding reported extended
sick leave or disability pension (data not shown). Terreehorst
et al.31 found that a large fraction of patients with atopic
dermatitis and asthma also suffered from rhinitis, and since
we did not ask about atopic dermatitis, it is possible that our
results are confounded by the effect of this illness.
In conclusion, the prevalence of both rhinitis and asthma
constitutes a threat to public health. Therefore, it is of
importance to evaluate the burden of these illnesses, not
only in clinical settings, but also in the general population. A
major finding in our study was that men and women in
different age categories are affected differently. In parti-
cular, older women with either or both rhinitis and asthma
reported the worst HRQL impairments. Such gender and age
differences should be taken into consideration in the care
and treatment of patients with rhinitis and asthma.
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